Skip to main content

Table 1 Characteristics of patients

From: Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes

Diagnosis Patient Gender Age, years Disease duration, years Disease activity Medications
RA 1 Male 75 10 DAS28 = 3.9
CRP = 19 mg/L
Methotrexate 15 mg
Prednisone 5
  2 Female 86 5 DAS28 = 4.7
CRP = 12 mg/L
Methotrexate 10 mg
Prednisone 7 mg
  3 Female 79 20 DAS28 = 6
CRP = 78 mg/L
Methotrexate 15 mg
Prednisone 10 mg
  4 Female 46 15 DAS28 = 4.1
CRP = 17 mg/L
Methotrexate 10 mg
Prednisone 2 mg
  5 Female 55 6 DAS28 = 3.7
CRP = 30 mg/L
Methotrexate 17.5 mg
Prednisone 5 mg
  6 Male 75 2 DAS28 = 4.2
CRP = 67 mg/L
Methotrexate 10 mg
Prednisone 7 mg
  7 Male 46 15 DAS28 = 3.6
CRP = 150 mg/L
Methotrexate 10 mg
Prednisone 5 mg
Infliximab (3 mg/kg)
OA 1 Male 54 8 CRP = 4 mg/L Paracetamol, NSAID
  2 Female 56 3 CRP = 6 mg/L Paracetamol
  3 Female 46 5 CRP = 4 mg/L Paracetamol, NSAID
  4 Female 65 7 CRP = 6 mg/L Paracetamol
  5 Male 55 5 CRP = 4 mg/L Paracetamol, Tramadol
MC 1 Female 55 3 CRP = 80 mg/L Paracetamol, NSAID
  2 Male 50 1 CRP = 34 mg/L Colchicine
  3 Male 74 1 CRP = 90 mg/L NSAID
AR 1 Male 75 1 CRP = 54 mg/L NSAID
  2 Male 30 2 CRP = 82 mg/L NSAID
  3 Male 45 1 CRP = 20 mg/L NSAID
  4 Female 20 1 CRP = 34 mg/L Paracetamol
  5 Male 52 1 CRP = 25 mg/L Paracetamol
  1. Patients were diagnosed with rheumatoid arthritis based on American College of Rheumatology 1987 diagnostic criteria at least 3 months before study entry and have active disease. The diagnosis of microcristalline arthritis was based on clinical and laboratory features. All patients fulfilled the American College of Rheumatology criteria for acute gouty or pseudogout. All patients gave informed consent. AR, reactive arthritis; CRP, C-reactive protein; DAS28, disease activity score using 28 joint counts; MC, microcristalline arthritis; NSAID, nonsteroidal anti-inflammatory drugs; OA, osteoarthritis; RA, rheumatoid arthritis.